Literature DB >> 12737533

Disposition of the flavonoid quercetin in rats after single intravenous and oral doses.

Khaled A Khaled1, Yousry M El-Sayed, Badr M Al-Hadiya.   

Abstract

The pharmacokinetic and mean time tissue distribution parameters, after a single 50-mg/kg dose of quercetin administered as intravenous bolus, oral solution, and oral suspension, were determined using rat as an animal model. Following intravenous administration, the elimination rate constant and the elimination half-life were found to be 0.0062 min(-1) and 111 min, respectively. Examining the mean time tissue distribution parameters reflected a strong binding affinity of the drug molecules to both plasma and tissue proteins. In addition, the low permeability rate of drug molecules in the peripheral system was demonstrated. Following the oral administration of the drug, the extent of absorption was greater from solution than from suspension. Moreover, the solution showed a shorter Tmax and a higher Cmax than suspension. The absolute bioavailability for the solution was 0.275 and that for suspension was 0.162. The mean residence time (MRT) and the mean absorption time (MAT) were higher for suspension, reflecting the need for dissolving the drug in order to be absorbed. The mean (in-vivo) dissolution time (MDT(in-vivo)) was 34.5 min. Thus, an oral quercetin formulation that can readily form a drug solution in the gastrointestinal tract may enhance the absorption of the drug.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12737533     DOI: 10.1081/ddc-120018375

Source DB:  PubMed          Journal:  Drug Dev Ind Pharm        ISSN: 0363-9045            Impact factor:   3.225


  13 in total

1.  Anti-inflammatory Effect and Toxicology Analysis of Oral Delivery Quercetin Nanosized Emulsion in Rats.

Authors:  Gabriela Hädrich; Gustavo Richter Vaz; Michelle Maidana; Jadel Muller Kratz; Gecioni Loch-Neckel; Daniely Cornélio Favarin; Alexandre de Paula Rogerio; Flávio Manoel Rodrigues da Silva; Ana Luiza Muccillo-Baisch; Cristiana Lima Dora
Journal:  Pharm Res       Date:  2015-12-18       Impact factor: 4.200

2.  Pharmacokinetics and modeling of quercetin and metabolites.

Authors:  Xiao Chen; Ophelia Q P Yin; Zhong Zuo; Moses S S Chow
Journal:  Pharm Res       Date:  2005-06-08       Impact factor: 4.200

3.  A comparison of the pharmacokinetics of three different preparations of total flavones of Hippophae rhamnoides in beagle dogs after oral administration.

Authors:  Jingze Duan; Yang Dang; Houjun Meng; Huizhen Wang; Ping Ma; Guowen Li; Tao Wu; Yan Xie
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2015-01-23       Impact factor: 2.441

4.  Anti-allergic effects of enzymatically modified isoquercitrin (α-oligoglucosyl quercetin 3-O-glucoside), quercetin 3-O-glucoside, α-oligoglucosyl rutin, and quercetin, when administered orally to mice.

Authors:  Toshiaki Makino; Misaki Kanemaru; Shuji Okuyama; Ryosuke Shimizu; Hisashi Tanaka; Hajime Mizukami
Journal:  J Nat Med       Date:  2013-03-14       Impact factor: 2.343

5.  Enhancing oral bioavailability of quercetin using novel soluplus polymeric micelles.

Authors:  Linghui Dian; Enjiang Yu; Xiaona Chen; Xinguo Wen; Zhengzan Zhang; Lingzhen Qin; Qingqing Wang; Ge Li; Chuanbin Wu
Journal:  Nanoscale Res Lett       Date:  2014-12-18       Impact factor: 4.703

Review 6.  Novel Investigations of Flavonoids as Chemopreventive Agents for Hepatocellular Carcinoma.

Authors:  Chen-Yi Liao; Ching-Chang Lee; Chi-chang Tsai; Chao-Wen Hsueh; Chih-Chiang Wang; I-Hung Chen; Ming-Kai Tsai; Mei-Yu Liu; An-Tie Hsieh; Kuan-Jen Su; Hau-Ming Wu; Shih-Chung Huang; Yi-Chen Wang; Chien-Yao Wang; Shu-Fang Huang; Yen-Cheng Yeh; Ren-Jy Ben; Shang-Tao Chien; Chin-Wen Hsu; Wu-Hsien Kuo
Journal:  Biomed Res Int       Date:  2015-12-16       Impact factor: 3.411

7.  Quercetin Is a Flavonoid Breast Cancer Resistance Protein Inhibitor with an Impact on the Oral Pharmacokinetics of Sulfasalazine in Rats.

Authors:  Yoo-Kyung Song; Jin-Ha Yoon; Jong Kyu Woo; Ju-Hee Kang; Kyeong-Ryoon Lee; Seung Hyun Oh; Suk-Jae Chung; Han-Joo Maeng
Journal:  Pharmaceutics       Date:  2020-04-26       Impact factor: 6.321

8.  Evaluation of the Mrp2-mediated flavonoid-drug interaction potential of quercetin in rats and in vitro models.

Authors:  Ju-Hee Oh; Joo Hyun Lee; Young-Joo Lee
Journal:  Asian J Pharm Sci       Date:  2019-01-16       Impact factor: 6.598

9.  A Novel Functional Emulsifier Prepared with Modified Cassava Amylose with Octenyl Succinic Anhydride and Quercetin: Preparation and Application in the Pickering Emulsion.

Authors:  Hailing Zhang; Haiming Chen; Shan Jiang; Xiaoning Kang
Journal:  Molecules       Date:  2021-11-15       Impact factor: 4.411

Review 10.  Anti-cancer properties of quercetin in osteosarcoma.

Authors:  Parisa Maleki Dana; Fatemeh Sadoughi; Zatollah Asemi; Bahman Yousefi
Journal:  Cancer Cell Int       Date:  2021-07-05       Impact factor: 5.722

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.